[CERO] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[CERO] CERo Therapeutics Holdings, Inc.
Announcement Date
28-Sep-2023
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- 76.50%
YoY- -492.94%
Quarter Report
CERO's Result
CERO's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 0 0 0 0 0 0 0 -
PBT -2,449 -2,300 -258 -308 -1,393 -482 276 -
Tax -0 -0 24 26 45 -274 539 -
NP -2,449 -2,300 -283 -334 -1,421 -482 -263 343.21%
Tax Rate - - - - - - -195.16% -
Total Cost 2,449 2,300 283 334 1,421 482 263 343.21%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS -0.15 -0.16 -0.05 -0.05 -0.21 -0.07 -0.04 141.56%
EPS Diluted -0.15 -0.16 -0.05 -0.05 -0.21 -0.07 -0.04 141.56%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.